Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 infections in children: Understanding diverse outcomes

Immunity(2022)10.1016/j.immuni.2022.01.014Source: DataRank Database

SARS-CoV-2 infections in children: Understanding diverse outcomes is a research paper published in Immunity (2022). On theSindex it has a DataRank of 0. It has been cited 119 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access119 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 10.63)OA: hybridTopics (57)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Petter Brodin ORCID

Live enrichment

PubMed:35093190 PMC:PMC8769938 OpenAlex:https://openalex.org/W4205473000

Vetenskapsrådet

Grant: 2021-06529

Swedish Research Council

Grant: unidentified

unidentified

National Institutes of Health

Rockefeller University

Garfield Weston Foundation

Karolinska Institutet

FWCI

10.63

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.cell.com/article/S1074761322000437/pdf

publisherhttp://www.cell.com/article/S1074761322000437/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1074761322000437?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761322000437?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.immuni.2022.01.014

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchKawasaki Disease and Coronary Complications0301 basic medicine0303 health sciences03 medical and health sciencesAdaptive ImmunityAge FactorsCOVID-19Disease SusceptibilityEnergy MetabolismHost-Pathogen InteractionsHumansPatient Outcome AssessmentSARS-CoV-2Systemic Inflammatory Response SyndromeTrauma Severity IndicesVirus Replicationpediatric multisystem inflammatory disease, COVID-19 related

MeSH Terms

COVID-19SARS-CoV-2Age FactorsDisease SusceptibilityEnergy MetabolismHumansVirus ReplicationTrauma Severity IndicesSystemic Inflammatory Response SyndromeHost-Pathogen InteractionsAdaptive ImmunityPatient Outcome Assessment

Keywords

AsymptomaticImmunologyBiologyImmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Incidence (geometry)Coronavirus disease 2019 (COVID-19)Intensive care medicineMedicineImmune systemInfectious disease (medical specialty)DiseaseInternal medicineTrauma Severity IndicesSARS-CoV-2Age FactorsCOVID-19Adaptive ImmunityVirus ReplicationSystemic Inflammatory Response SyndromePatient Outcome AssessmentPerspectiveHost-Pathogen InteractionsHumansDisease SusceptibilityEnergy Metabolism

Sustainable Development Goals

SDG 3: 3. Good health